Literature DB >> 6986796

Effect of atropine on secretion from intact and transplanted pancreas in dog.

M V Singer, T E Solomon, M I Grossman.   

Abstract

In dogs with a fistula of the intact pancreas and a transplanted portion of pancreas, we studied the effect of atropine on the pancreatic secretory response to intravenous caerulein and to intestinal perfusion with tryptophan, both given with a secretin background. Atropine (50 micrograms . kg-1 given as an intravenous bolus injection followed by 20 micrograms . kg-1 . h-1 iv infusion) depressed bicarbonate and protein secretion from intact pancreas during stimulation by secretin alone (250 ng . kg-1 . h-1) but did not suppress the increment in bicarbonate secretion in response to caerulein or tryptophan given against the secretin background. In intact pancreas, atropine suppressed protein secretion in response to tryptophan but not in response to caerulein. Atropine had no significant effect on the secretion of bicarbonate and protein from transplanted pancreas in response to secretin, caerulein, or tryptophan. Thus, the only significant effect of atropine on bicarbonate and protein secretion from intact and transplanted pancreas in response to intravenous caerulein or intraduodenal tryptophan, both given against a background of secretin, was inhibition of the protein response to tryptophan in the intact pancreas. These findings are compatible with the hypothesis that pancreatic protein secretion in response to intraduodenal tryptophan is mediated in part by a cholinergic enteropancreatic reflex.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6986796     DOI: 10.1152/ajpgi.1980.238.1.G18

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  16 in total

1.  [Effect of pancreatic innervation on exocrine secretory performance of the pancreas].

Authors:  H Köhler; R Nustede; M Barthel; A Schafmayer; H J Peiper
Journal:  Langenbecks Arch Chir       Date:  1992

2.  Inhibitory effects of pirenzepine on cholecystokinin and secretin stimulation on exocrine and endocrine rat pancreas.

Authors:  M Otsuki; Y Okabayashi; T Nakamura; M Fujii; T Oka; S Tani; S Baba
Journal:  Dig Dis Sci       Date:  1987-10       Impact factor: 3.199

3.  Subtypes of muscarinic receptors in canine pancreatic secretion in vivo and in vitro.

Authors:  S J Konturek; J Jaworek; J Tasler; M Cieszkowski; N Yanaihara
Journal:  Int J Pancreatol       Date:  1987-02

4.  Pancreatic polypeptide response to a meal before and after cutting the extrinsic nerves of the upper gastrointestinal tract and the pancreas in the dog.

Authors:  W Niebel; V E Eysselein; M V Singer
Journal:  Dig Dis Sci       Date:  1987-09       Impact factor: 3.199

5.  Experimental evidence for a vagally mediated and cholecystokinin-independent enteropancreatic reflex.

Authors:  G M Fried; W D Ogden; T Sakamoto; G H Greeley; J C Thompson
Journal:  Ann Surg       Date:  1985-07       Impact factor: 12.969

6.  Secretion of protein and epidermal growth factor (EGF) by transplanted human pancreas.

Authors:  J W Konturek; M Buesing; U T Hopt; J Stachura; H D Becker; S J Konturek
Journal:  Int J Pancreatol       Date:  1992-08

7.  The role of nicotinic receptors in dog pancreatic exocrine secretion.

Authors:  M A Devaux; G R Diaz; K Kubota; D F Magee; H Sarles
Journal:  Br J Pharmacol       Date:  1983-04       Impact factor: 8.739

8.  Role of cholecystokinin in intestinal phase of human pancreatic secretion.

Authors:  W R Brugge; C A Burke; R S Izzo; M Praissman
Journal:  Dig Dis Sci       Date:  1987-02       Impact factor: 3.199

9.  Neural pathways for the release of gastrin, cholecystokinin, and pancreatic polypeptide after a meal in dogs. Role of gastric and splanchnic nerves.

Authors:  C D Johnson; J A Chayvialle; M A Devaux; H Sarles
Journal:  Dig Dis Sci       Date:  1986-12       Impact factor: 3.199

10.  Studies of the role of opioids in control of human pancreatic secretion.

Authors:  C P Dooley; C Saad; J E Valenzuela
Journal:  Dig Dis Sci       Date:  1988-05       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.